PVP Ventures Limited has announced a strategic move into the healthcare sector with the acquisition of a significant stake in 7Med India Pvt. Ltd. (7Med), a leading provider of renal care services. The Board of Directors approved the acquisition at a meeting on August 28, 2025, marking a key milestone in PVP’s plan to build a new-age global healthcare services platform focused on illness, wellness, and care.
Under the agreement, PVP Ventures will initially acquire a 41.2% stake in 7Med, with a clear path to increasing its holding to a majority stake of 76% over time. The acquisition involves a combination of primary and secondary stake purchase for an outlay of approximately INR 127 crore, with subsequent investments linked to agreed financial milestones over the coming years.
Headquartered in the Delhi NCR region, 7Med was founded by specialists in Nephrology, Urology, and Dialysis, who have previously held leadership roles at organizations like Fresenius Medical Care, B. Braun Medical, Medanta, and Fortis. The company employs over 450 professionals and is dedicated to providing holistic, world-class care to patients suffering from kidney failure.
7Med operates a profitable network of 22 centres, including shop-in-shop dialysis facilities within top hospitals and standalone dialysis units across six states, along with four super-specialty hospitals focused on Nephrology and Urology.
The company is already among the top five organized players in India’s renal care sector and reported an EBITDA of approximately INR 10 crore in the current financial year. With PVP’s investment, 7Med aims to expand its network, strengthen healthcare infrastructure in Tier 2 and Tier 3 cities, and reach an estimated EBITDA of INR 50 crore within four years.
